BioCentury
ARTICLE | Financial News

Immunovaccine completes private placement

March 11, 2013 7:00 AM UTC

Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date completed: 3/5/13 Type: Private placement Raised: C$1.6 million ($1.6 million) Shares: 4.9 million Price: C$0.33 ...